Most recently, inhibiting the interaction between the blood protein fibrinogen and ITGAM/CD11b reduced synaptic elimination and cognitive decline in a mouse model of Alzheimer’s disease (Merlini et al., 2019), providing strong evidence that ITGAM/CD11b function contributes to disease development. This evidence concerns the gene ITGAM and early-onset autosomal dominant Alzheimer disease.